...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Muscle atrophy in muscle-specific tyrosine kinase (MuSK)-related myasthenia gravis.
【24h】

Muscle atrophy in muscle-specific tyrosine kinase (MuSK)-related myasthenia gravis.

机译:肌肉特异性酪氨酸激酶(MuSK)相关的重症肌无力中的肌肉萎缩。

获取原文
获取原文并翻译 | 示例
           

摘要

Myasthenia gravis (MG) with muscle-specific tyrosine kinase (MuSK) antibody (MuSK-MG) is often associated with prominent facial and bulbar muscle atrophy. It remains unclear whether the muscle atrophy is a consequence of long-term corticosteroid treatment, or of the disease process per se. Herein, we report a steroid-naive patient with MuSK-MG who presented with severe weakness and marked atrophy of the facial and tongue muscles.
机译:重症肌无力(MG)带有肌肉特异性酪氨酸激酶(MuSK)抗体(MuSK-MG)通常与面部和延髓肌萎缩症相关。尚不清楚肌肉萎缩是长期皮质类固醇治疗的结果,还是疾病过程本身的结果。本文中,我们报道了一位初次使用类固醇的MuSK-MG患者,表现出严重的无力和明显的面部和舌头肌肉萎缩。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号